feed,title,long_url,short_url
MarketWatch,Prothena sells ATTR amyloidosis portfolio to Novo Nordisk for up to $1.2 billion,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/uAdW15T-5IM/story.aspx,https://on.mktw.net/3wBGu0b
